Business News

China approves first domestic anti-COVID pill, Azvudine, as it battles new Omicron outbreaks



China approves first domestic anti-COVID pill, Azvudine, as it battles new Omicron outbreaks | Fortune



You need to enable JavaScript to view this site.


Source link

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button